News

Page, whose legal name was Kylie Pylant, had been taking her AA meetings seriously and even stepped up to lead some sessions ...
Prices are falling for the popular obesity treatments semaglutide (Wegovy) and tirzepatide (Zepbound), but steady access to the drugs remains challenging. The medications still amount to around $500 ...
The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
As Oasis kicks off a reunion tour July 4, a new book of interviews with the Gallagher brothers recalls their sometimes ...
Charles got his start writing for the comedy series “Fridays,” an “SNL” knockoff that aired on ABC on Friday nights from 1980 ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang We are still reporting. If you are a current or former FDA employee or someone in the industry with information about the agency, the ...
And the barrier to entry remains high, even for Medicaid patients in those few states that have agreed to cover the drugs without a federal mandate. Case in point: In South Carolina, where more than ...
CHARLESTON, S.C. — When Page Campbell's doctor recommended that she try an injectable prescription drug called Wegovy to lose weight before scheduling bariatric surgery, she readily agreed.
But commercial plans apply access restrictions to just 35% of the drugs they cover. The percentage of covered drugs subject to access restrictions is 49% at Medicare plans and 63% at Medicaid plans.
Donald Trump’s team essentially gutted the Biden administration’s plan on Friday as part of a sprawling 438-page regulation update that tweaks how beneficiaries get drug and private medical coverage, ...